243 related articles for article (PubMed ID: 22784711)
1. First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer.
Brizuela L; Ader I; Mazerolles C; Bocquet M; Malavaud B; Cuvillier O
Mol Cancer Ther; 2012 Sep; 11(9):1841-51. PubMed ID: 22784711
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; Teissié J; Malavaud B; Cuvillier O
Cancer Res; 2005 Dec; 65(24):11667-75. PubMed ID: 16357178
[TBL] [Abstract][Full Text] [Related]
3. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis.
Kariya Y; Kihara A; Ikeda M; Kikuchi F; Nakamura S; Hashimoto S; Choi CH; Lee YM; Igarashi Y
Genes Cells; 2005 Jun; 10(6):605-15. PubMed ID: 15938718
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.
Matula K; Collie-Duguid E; Murray G; Parikh K; Grabsch H; Tan P; Lalwani S; Garau R; Ong Y; Bain G; Smith AD; Urquhart G; Bielawski J; Finnegan M; Petty R
BMC Cancer; 2015 Oct; 15():762. PubMed ID: 26493335
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer.
Oskouian B; Sooriyakumaran P; Borowsky AD; Crans A; Dillard-Telm L; Tam YY; Bandhuvula P; Saba JD
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17384-9. PubMed ID: 17090686
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.
Pchejetski D; Doumerc N; Golzio M; Naymark M; Teissié J; Kohama T; Waxman J; Malavaud B; Cuvillier O
Mol Cancer Ther; 2008 Jul; 7(7):1836-45. PubMed ID: 18644996
[TBL] [Abstract][Full Text] [Related]
7. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
Uranbileg B; Ikeda H; Kurano M; Enooku K; Sato M; Saigusa D; Aoki J; Ishizawa T; Hasegawa K; Kokudo N; Yatomi Y
PLoS One; 2016; 11(2):e0149462. PubMed ID: 26886371
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.
Degagné E; Pandurangan A; Bandhuvula P; Kumar A; Eltanawy A; Zhang M; Yoshinaga Y; Nefedov M; de Jong PJ; Fong LG; Young SG; Bittman R; Ahmedi Y; Saba JD
J Clin Invest; 2014 Dec; 124(12):5368-84. PubMed ID: 25347472
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer.
Ling B; Chen L; Alcorn J; Ma B; Yang J
Invest New Drugs; 2011 Apr; 29(2):396-9. PubMed ID: 20041340
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.
Brizuela L; Martin C; Jeannot P; Ader I; Gstalder C; Andrieu G; Bocquet M; Laffosse JM; Gomez-Brouchet A; Malavaud B; Sabbadini RA; Cuvillier O
Mol Oncol; 2014 Oct; 8(7):1181-95. PubMed ID: 24768038
[TBL] [Abstract][Full Text] [Related]
11. Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation.
Colié S; Van Veldhoven PP; Kedjouar B; Bedia C; Albinet V; Sorli SC; Garcia V; Djavaheri-Mergny M; Bauvy C; Codogno P; Levade T; Andrieu-Abadie N
Cancer Res; 2009 Dec; 69(24):9346-53. PubMed ID: 19934311
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1 Phosphate Lyase Regulates Sensitivity of Pancreatic Beta-Cells to Lipotoxicity.
Tang Y; Plötz T; Gräler MH; Gurgul-Convey E
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639233
[TBL] [Abstract][Full Text] [Related]
13. Recent Insight into the Role of Sphingosine-1-Phosphate Lyase in Neurodegeneration.
Wieczorek I; Strosznajder RP
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047151
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm.
Kihara A; Ikeda M; Kariya Y; Lee EY; Lee YM; Igarashi Y
J Biol Chem; 2003 Apr; 278(16):14578-85. PubMed ID: 12584204
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKε To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection.
Vijayan M; Xia C; Song YE; Ngo H; Studstill CJ; Drews K; Fox TE; Johnson MC; Hiscott J; Kester M; Alexander S; Hahm B
J Immunol; 2017 Jul; 199(2):677-687. PubMed ID: 28600291
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge.
Stepanovska B; Lange AI; Schwalm S; Pfeilschifter J; Coldewey SM; Huwiler A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069843
[TBL] [Abstract][Full Text] [Related]
17. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme.
Ikeda M; Kihara A; Kariya Y; Lee YM; Igarashi Y
Biochem Biophys Res Commun; 2005 Apr; 329(2):474-9. PubMed ID: 15737611
[TBL] [Abstract][Full Text] [Related]
19. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
[TBL] [Abstract][Full Text] [Related]
20. Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease.
Ceccom J; Loukh N; Lauwers-Cances V; Touriol C; Nicaise Y; Gentil C; Uro-Coste E; Pitson S; Maurage CA; Duyckaerts C; Cuvillier O; Delisle MB
Acta Neuropathol Commun; 2014 Jan; 2():12. PubMed ID: 24468113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
